Literature DB >> 34427639

Noninfectious Pulmonary Complications Associated With Anti-Integrin Therapy: A Case Report and Systematic Review of the Literature.

David Dulaney1, Priya Dave2, Samantha Walsh3, Saurabh Mehandru4, Jean-Frederic Colombel4, Manasi Agrawal4.   

Abstract

Entities:  

Keywords:  adverse event; anti-integrin; eosinophilic; inflammatory bowel disease; pulmonary; vedolizumab

Mesh：

Substances：

Year:  2022        PMID： 34427639      PMCID： PMC9122753          DOI： 10.1093/ibd/izab212

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   7.290


× No keyword cloud information.
  14 in total

1.  Vedolizumab-Induced De Novo Extraintestinal Manifestations.

Authors:  Liege I Diaz; Tara Keihanian; Ingrid Schwartz; Su Bin Kim; Fernando Calmet; Maria Alejandra Quintero; Maria T Abreu
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-02

2.  Vedolizumab-Associated Acute Respiratory Distress Syndrome.

Authors:  Sudheer Nambiar; Asha Karippot; Tony Oliver
Journal:  Am J Ther       Date:  2018 Sep/Oct       Impact factor: 2.688

3.  Pulmonary Manifestation of Crohn's Disease Developed Under Treatment With Vedolizumab.

Authors:  Donata Lissner; Rainer Glauben; Kristina Allers; Elena Sonnenberg; Christoph Loddenkemper; Thomas Schneider; Britta Siegmund
Journal:  Am J Gastroenterol       Date:  2018-01       Impact factor: 10.864

4.  Mucosal Eosinophilia Is an Independent Predictor of Vedolizumab Efficacy in Inflammatory Bowel Diseases.

Authors:  Erin M Kim; Cara Randall; Renee Betancourt; Staci Keene; Amy Lilly; Mark Fowler; Evan S Dellon; Hans H Herfarth
Journal:  Inflamm Bowel Dis       Date:  2020-07-17       Impact factor: 5.325

5.  Vedolizumab as induction and maintenance therapy for ulcerative colitis.

Authors:  Brian G Feagan; Paul Rutgeerts; Bruce E Sands; Stephen Hanauer; Jean-Frédéric Colombel; William J Sandborn; Gert Van Assche; Jeffrey Axler; Hyo-Jong Kim; Silvio Danese; Irving Fox; Catherine Milch; Serap Sankoh; Tim Wyant; Jing Xu; Asit Parikh
Journal:  N Engl J Med       Date:  2013-08-22       Impact factor: 91.245

6.  Vedolizumab as induction and maintenance therapy for Crohn's disease.

Authors:  William J Sandborn; Brian G Feagan; Paul Rutgeerts; Stephen Hanauer; Jean-Frédéric Colombel; Bruce E Sands; Milan Lukas; Richard N Fedorak; Scott Lee; Brian Bressler; Irving Fox; Maria Rosario; Serap Sankoh; Jing Xu; Kristin Stephens; Catherine Milch; Asit Parikh
Journal:  N Engl J Med       Date:  2013-08-22       Impact factor: 91.245

Review 7.  Drug-induced eosinophilic pneumonia: A review of 196 case reports.

Authors:  Carmi Bartal; Iftach Sagy; Leonid Barski
Journal:  Medicine (Baltimore)       Date:  2018-01       Impact factor: 1.889

8.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.

Authors:  Matthew J Page; Joanne E McKenzie; Patrick M Bossuyt; Isabelle Boutron; Tammy C Hoffmann; Cynthia D Mulrow; Larissa Shamseer; Jennifer M Tetzlaff; Elie A Akl; Sue E Brennan; Roger Chou; Julie Glanville; Jeremy M Grimshaw; Asbjørn Hróbjartsson; Manoj M Lalu; Tianjing Li; Elizabeth W Loder; Evan Mayo-Wilson; Steve McDonald; Luke A McGuinness; Lesley A Stewart; James Thomas; Andrea C Tricco; Vivian A Welch; Penny Whiting; David Moher
Journal:  BMJ       Date:  2021-03-29

9.  Pulmonary eosinophilia associated to treatment with natalizumab.

Authors:  Elena Curto; Elvira Munteis-Olivas; Eva Balcells; M Marisol Domínguez-Álvarez
Journal:  Ann Thorac Med       Date:  2016 Jul-Sep       Impact factor: 2.219

10.  Anti-α4β7 therapy targets lymphoid aggregates in the gastrointestinal tract of HIV-1-infected individuals.

Authors:  Mathieu Uzzan; Minami Tokuyama; Adam K Rosenstein; Costin Tomescu; Ivo N SahBandar; Huaibin M Ko; Louise Leyre; Anupa Chokola; Emma Kaplan-Lewis; Gabriela Rodriguez; Akihiro Seki; Michael J Corley; Judith Aberg; Annalena La Porte; Eun-Young Park; Hideki Ueno; Ioannis Oikonomou; Itai Doron; Iliyan D Iliev; Benjamin K Chen; Jennifer Lui; Timothy W Schacker; Glaucia C Furtado; Sergio A Lira; Jean-Frederic Colombel; Amir Horowitz; Jean K Lim; Nicolas Chomont; Adeeb H Rahman; Luis J Montaner; Lishomwa C Ndhlovu; Saurabh Mehandru
Journal:  Sci Transl Med       Date:  2018-10-03       Impact factor: 17.956
View more
  1 in total

1.  Case report: Eosinophilic pneumonia associated with vedolizumab therapy in a patient with ulcerative colitis.

Authors:  Wanwan Zhu; Tianhao Zhao; Jun Wei; Damin Chai; Cancan Zhao; Yu Zhu; Min Deng
Journal:  Front Med (Lausanne)       Date:  2022-08-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.